Publication date | Issuer | Person discharging managerial responsibilities | Position | Closely associated | Nature of transaction | Instrument name | Intrument type | ISIN | Transaction date | Volume | Unit | Price | Currency | Status | Details |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
08/12/2023 | Hansa Biopharma AB | Sören Tulstrup | Chief Executive Officer (CEO)/Managing Directory | Acquisition | Hansa Biopharma AB | Share | SE0002148817 | 07/12/2023 | 5,000 | Quantity | 23.02836 | SEK | Notification | ||
02/08/2022 | Hansa Biopharma AB | Peter Nicklin | Chairman of the Board of Directors | Acquisition | Hansa Biopharma AB | Share | SE0002148817 | 19/07/2022 | 14,500 | Quantity | 71.185702 | SEK | History | Notification | |
22/06/2022 | Hansa Biopharma AB | Donato Spota | Chief Financial Officer (CFO) | Acquisition | Hansa Biopharma AB | Share | SE0002148817 | 17/06/2022 | 10,311 | Quantity | 0.00 | SEK | Notification | ||
22/06/2022 | Hansa Biopharma AB | Donato Spota | Chief Financial Officer (CFO) | Disposal | Hansa Biopharma AB | Share | SE0002148817 | 17/06/2022 | 4,638 | Quantity | 49.99 | SEK | Notification | ||
22/06/2022 | Hansa Biopharma AB | Anne Säfström Lanner | Other member of the company's administrative, management or supervisory body | Disposal | Ordinary Share HNSA | Share | SE0002148817 | 17/06/2022 | 2,685 | Quantity | 49.99 | SEK | Notification | ||
22/06/2022 | Hansa Biopharma AB | Henk Doude van Troostwijk | Other member of the company's administrative, management or supervisory body | Disposal | Hansa Biopharma AB | Share | SE0002148817 | 17/06/2022 | 2,591 | Quantity | 49.99 | SEK | Notification | ||
22/06/2022 | Hansa Biopharma AB | Henk Doude van Troostwijk | Other member of the company's administrative, management or supervisory body | Acquisition | Hansa Biopharma AB | Share | SE0002148817 | 17/06/2022 | 5,155 | Quantity | 0.00 | SEK | Notification | ||
22/06/2022 | Hansa Biopharma AB | Sören Tulstrup | Chief Executive Officer (CEO)/Managing Directory | Disposal | Hansa Biopharma AB | Share | SE0002148817 | 17/06/2022 | 3,925 | Quantity | 49.99 | SEK | History | Notification | |
22/06/2022 | Hansa Biopharma AB | Sören Tulstrup | Chief Executive Officer (CEO)/Managing Directory | Acquisition | Hansa Biopharma AB | Share | SE0002148817 | 17/06/2022 | 3,925 | Quantity | 49.99 | SEK | Revised | Notification | |
22/06/2022 | Hansa Biopharma AB | Sören Tulstrup | Chief Executive Officer (CEO)/Managing Directory | Allotment | Hansa Biopharma AB | Share | SE0002148817 | 17/06/2022 | 15,466 | Quantity | 0.00 | SEK | Notification |